OMCL - Omnicell Inc

Omnicell, Inc., provides medication management automation solutions and adherence tools for health care systems and pharmacies in the United States and internationally. The company is headquartered in Mountain View, California.

52W High

$55.74

52W Low

$22.66

MA Status:

50D: Above 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.82

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

64.22

Forward P/E (<15 better)

29.50

EV/EBITDA (<8 favorable)

14.09

EV/Revenue (<3 favorable)

1.26

P/S (TTM) (<3 favorable)

1.28

P/B (<3 favorable)

1.17

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

1.79%

Institutions (25–75% balanced)

105.71%

Shares Outstanding

45,934,300

Float

44,819,400

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

1,149,529,000

Gross Profit (TTM)

504,451,000

EPS (TTM)

0.50

Profit Margin (>10% good)

0.02%

Operating Margin (TTM) (higher better)

0.03%

ROE (TTM) (>15% strong)

0.02%

EPS YoY (Quarterly) (>10% good)

0.50

Revenue YoY (Quarterly) (>8% good)

0.05

Momentum

Bearish momentum

Value

0.4645

0.5891

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025